Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
(NASDAQ: VTRS) Delayed: 15.38 +0.01 (0.07%)
Previous Close $15.37    52 Week High $ 
Open $15.44    52 Week Low $ 
Day High $15.52    P/E N/A 
Day Low $15.07    EPS $ 
Volume 12,531,236